Paradigm Biopharmaceuticals reported AUD1000 in Interest Expense on Debt for its fiscal semester ending in June of 2025.





Interest Expense On Debt Change Date
Avita Medical AUD 1.25M 100K Jun/2025
Medical Developments International AUD 18K 3K Jun/2025
Neuren Pharmaceuticals AUD 0 0 Jun/2024
PYC Therapeutics AUD 17K 11K Jun/2025
Telix Pharmaceuticals AUD 7.62M 11.22M Dec/2025